¾È³çÇϼ¼¿ä, À̹ø ÁÖ ¹ßÇ¥ÀÚ ½ÂÀ±ÀÔ´Ï´Ù.
Á¦°¡ À̹ø¿¡ ¼±Á¤ÇÑ ³í¹®Àº 2020³â 10¿ù science advances¿¡ ÃâÆÇµÈ ‘CD1d1 intrinsic signaling in macrophages controls NLRP3 inflammasome expression during inflammation’ ÀÔ´Ï´Ù.
À§ ³í¹®Àº major histocompatibility complex class I–like proteinÀÎ CD1d1ÀÌ macrophage¿¡¼ NLRP3 inflammasome expression¿¡ ¾î¶² ¿µÇâÀ» ³¢Ä¡´ÂÁö ¹àÈù ³í¹®ÀÔ´Ï´Ù.
NLRP3 inflammasomeÀº ±âº»ÀûÀ¸·Î tissue repair¿¡ °ü¿©ÇÏÁö¸¸ dysregulationµÇ´Â »óȲ¿¡¼´Â Inflammatory bowel disease(IBD)¸¦ À¯¹ßÇÑ´Ù°í ¾Ë·ÁÁ® ÀÖ½À´Ï´Ù.
ÀÌ·¯ÇÑ IBD»óȲ°ú °ü·ÃÇÏ¿© Colonic tissue¿¡ NLRP3 inflammasome¿¡ ´ëÇÑ DSS°¡ ¹ÌÄ¡´Â ¸ÞÄ¿´ÏÁòÀº Àß ¹àÇôÁ® ÀÖÁö ¾Ê½À´Ï´Ù.
º» ³í¹®Àº DSS-induced colitis »óȲ¿¡¼ CD1d1ÀÌ CD1d1ÀÇ ligandÁß ÇϳªÀÎ iGb3¿Í °áÇսÿ¡´Â NLRP3 inflammasome pathway¿¡ ¿µÇâÀ» ¹ÌÃÄ NLRP3 hyperactivationÀ» ¸·´Â °ÍÀ» ¹àÇô³Â½À´Ï´Ù.
°ü·Ã ¸ÞÄ¿´ÏÁòÀ¸·Î´Â iGb3°¡ CD1d1°ú °áÇÕÇϸé AKT-STAT1-PRDX1-NF-kB signalingÀ» ÅëÇØ NLRP3¿¡ RelA bindingÀ» inhibitÇÔÀ» È®ÀÎÇÏ¿´½À´Ï´Ù.
°á°úÀûÀ¸·Î, NLRP3ÀÇ substrateÀÎ IL-1B, IL-18µµ °¨¼ÒÇÔÀ» È®ÀÎÇÏ¿´½À´Ï´Ù.
¿½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.
°¨»çÇÕ´Ï´Ù.
½ÂÀ± ¿Ã¸²
³í¹® ¸µÅ© : https://www.science.org/doi/10.1126/sciadv.aaz7290?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed